Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Share News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: Redx CEO ups stake

Wed, 23rd Dec 2020 15:52

(Sharecast News) - Redx Pharma revealed on Wednesday that chief executive Lisa Anson had acquired 39,998 ordinary shares in the AIM-listed drug discovery and development group.
Anson, who was appointed to the board of Redx back in April 2018, purchased the shares on Tuesday at an average price e of 50.0p each, for a total value of £19,999.

Back in August, Redx shares surged after it signed a licensing agreement with AstraZeneca for its porcupine inhibitor for fibrotic diseases, RXC006.

Under the terms of the agreement, AstraZeneca will pay Redx several early milestones that amount to $17.0m.

As of 1550 GMT, Redx shares were up 11.43% at 58.50p.

Top Director Buys

De La Rue (DLAR)
Director name: Vacher,Clive
Amount purchased: 80,000 @ 151.44p
Value: £121,152.00

Rit Capital Partners (RCP)
Director name: Sorrell,Jonathan
Amount purchased: 2,429 @ 2,045.00p
Value: £49,673.05

Bbgi Global Infrastructure S.a. Npv (di) (BBGI)
Director name: Denny,Michael
Amount purchased: 20,000 @ 168.00p
Value: £33,600.00

Paragon Banking Group (PAG)
Director name: Terrington,Nigel S
Amount purchased: 4,518 @ 457.00p
Value: £20,647.26

Redx Pharma (REDX)
Director name: Anson,Lisa
Amount purchased: 39,998 @ 50.00p
Value: £19,999.00

De La Rue (DLAR)
Director name: Vacher,Clive
Amount purchased: 13,000 @ 151.44p
Value: £19,687.20

Origin Enterprises (OGN)
Director name: Kirkpatrick,Helen
Amount purchased: 5,000 @ 343.00p
Value: £19,036.50

Paragon Banking Group (PAG)
Director name: Woodman,Richard
Amount purchased: 2,904 @ 457.00p
Value: £13,271.28

Ceps (CEPS)
Director name: Horner,David
Amount purchased: 30,000 @ 30.00p
Value: £9,000.00

Sutton Harbour Group (SUH)
Director name: Miller,Graham Scott
Amount purchased: 27,711 @ 18.00p
Value: £4,987.98

Ceps (CEPS)
Director name: Horner,David
Amount purchased: 10,000 @ 23.25p
Value: £2,325.00

Ceps (CEPS)
Director name: Horner,David
Amount purchased: 10,000 @ 23.00p
Value: £2,300.00

Integrafin Holding (IHP)
Director name: Gunby,Jonathan
Amount purchased: 28 @ 527.00p
Value: £147.56

Integrafin Holding (IHP)
Director name: Scott,Alexander
Amount purchased: 28 @ 527.00p
Value: £147.56

Integrafin Holding (IHP)
Director name: Taylor,Ian
Amount purchased: 28 @ 527.00p
Value: £147.56



Top Director Sells

Coats Group (COA)
Director name: Sharma,Rajiv
Amount sold: 2,678,386 @ 69.41p
Value: £1,859,040.96

Coats Group (COA)
Director name: Sharma,Rajiv
Amount sold: 550,978 @ 69.41p
Value: £382,428.32

Touchstone Exploration Inc Npv (di) (TXP)
Director name: Baay,Paul R.
Amount sold: 300,000 @ 117.00p
Value: £350,999.99

Coats Group (COA)
Director name: Sharma,Rajiv
Amount sold: 352,397 @ 69.41p
Value: £244,595.24

De La Rue (DLAR)
Director name: Vacher,Clive
Amount sold: 93,000 @ 151.40p
Value: £140,802.01

Redcentric (RCN)
Director name: Brotherton,Peter
Amount sold: 97,481 @ 110.00p
Value: £107,229.10

Countryside Properties (CSP)
Director name: McPherson,Iain
Amount sold: 6,998 @ 417.70p
Value: £29,230.65

Countryside Properties (CSP)
Director name: Scott,Mike
Amount sold: 4,245 @ 417.70p
Value: £17,731.37

Redcentric (RCN)
Director name: Senior,David
Amount sold: 14,550 @ 110.00p
Value: £16,005.00

More News
19 Apr 2024 16:02

IN BRIEF: Redx Pharma shareholders approve AIM delisting plans

Redx Pharma PLC - clinical-stage biotechnology company - Shareholders pass resolution by 99.75% margin at general meeting to approve cancelling shares on AIM in London. This is now expected to take place on May 1, with last day of trading on April 30. Says it remains the company's intention to provide a matched bargain facility to assist shareholders wishing to trade in shares following the AIM delisting. Says it will make further details available in "due course" on its website.

Read more
12 Apr 2024 15:35

Director dealings: Redx Pharma CEO ups stake

(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.

Read more
2 Apr 2024 16:57

LONDON MARKET CLOSE: Europe down after Easter holiday weekend

(Alliance News) - The FTSE 100 took a hit on Tuesday, after a boost from London's miners and oil firms were not enough to lift the index.

Read more
2 Apr 2024 12:15

Redx Pharma plummets on plans to delist from AIM

(Alliance News) - Redx Pharma PLC shares fell on Tuesday, after it said it intends to cancel its shares from trading on AIM in London.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:50

AIM WINNERS & LOSERS: 88 Energy finds oil at Hickory-1; Redx to delist

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
14 Feb 2024 09:34

IN BRIEF: Redx Pharma clarifies not currently pursuing US listing

Redx Pharma PLC - Macclesfield, England-based clinical-stage biotechnology company - Responds to a Times article published on Tuesday saying RedX is looking to list its shares in New York. Redx says it "wishes to clarify that it is not currently in any process relating to a listing in the US, nor any other jurisdiction".

Read more
7 Feb 2024 11:08

Redx Pharma shares skyrocket on deal to sell inhibitor program

(Alliance News) - Redx Pharma PLC on Wednesday said it has struck a deal to sell Kirsten rat sarcoma virus inhibitor program to Dublin-based Jazz Pharmaceuticals PLC.

Read more
7 Feb 2024 09:29

AIM WINNERS & LOSERS: Verditek falls on cash shell plans

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
15 Dec 2023 21:09

EARNINGS AND TRADING: Redx full year revenue tumbles; loss widens

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
18 Oct 2023 12:30

Redx Pharma looks to progress portfolio after raising GBP14.1 million

(Alliance News) - Redx Pharma PLC on Wednesday said that it has conditionally raised around GBP14.1 million by way of a subscription for 54.1 million shares at 26 pence each.

Read more
21 Aug 2023 10:29

AIM WINNERS & LOSERS: Fulcrum Utility to leave AIM as loss widens

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
21 Aug 2023 09:33

Redx Pharma says RXC007 receives orphan drug designation from US FDA

(Alliance News) - Redx Pharma PLC on Monday said its RXC007 drug has received orphan drug designation from the US Food & Drug Administration for the treatment of idiopathic pulmonary fibrosis, a condition causing breathing difficulty due to lung scarring.

Read more
21 Aug 2023 07:43

LONDON BRIEFING: Crest Nicholson lowers annual profit forecast

(Alliance News) - Stocks in London are called flat on Monday, with little in the way of economic data or company updates to reignite risk appetite.

Read more
10 Jul 2023 11:22

Redx Pharma extends term of outstanding notes with two lenders to 2024

(Alliance News) - Redx Pharma PLC on Monday said it extended the term of its outstanding convertible loan notes issued to two lenders RM Special Holdings 3 LLC, otherwise known as Redmile, and Sofinnova Crossover I SLP by a year.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.